Cargando…
Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany
Bacillus Calmette-Guérin (BCG) vaccine is known to have “bystander benefits” in protecting against heterologous infections; interim analysis of the “ACTIVATE” trial shows protection against respiratory infections in the elderly population. Epidemiologic studies suggest a potential benefit of BCG vac...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475553/ https://www.ncbi.nlm.nih.gov/pubmed/33544024 http://dx.doi.org/10.1080/21645515.2021.1872344 |